The Department is developing technology to efficiently cope with infection by new viruses through the diagnosis, prevention, treatment and spread prevention of high-risk, unspecific, new, and variant viruses that are highly probable to be introduced to Korea, including MERS and Zika viruses.
Development of technology for supersensitive diagnosis, vaccines, therapeutics, and spread prevention against unspecific, new, and variant viruses that are highly probable to be introduced to Korea
Transfer of technology about high-efficacy, low-molecular weight COVID-19 therapeutic candidates